Anzeige
Meldung des Tages: Der Countdown läuft! Comeback-Land, Wahljahr: Warum diese Aktie 2026 spannend werden könnte

CollPlant Biotechnologies Aktie News

Aktie
WKN:  A1CY27 ISIN:  IL0004960188 US-Symbol:  CLGN Branche:  Biotechnologie Land:  Israel
1,47 €
+0,02 €
+1,38%
08:01:26 Uhr
Depot/Watchlist
Marktkapitalisierung *
16,44 Mio. €
Streubesitz
77,61%
KGV
-2,48
Index-Zuordnung
-

CollPlant Biotechnologies News

26.11.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire
18.11.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS PR Newswire
27.10.25 - PR Newswire
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada PR Newswire
20.10.25 - PR Newswire
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
CollPlant's rhCollagen-​Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology PR Newswire
16.10.25 - PR Newswire
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
First-​in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-​Based BioInk PR Newswire
30.09.25 - PR Newswire
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
CollPlant Biotechnologies Announces Positive Results from non-​clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler PR Newswire
15.09.25 - PR Newswire
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
CollPlant Expands the Distribution of its VergenixSTR Product in Europe PR Newswire
02.09.25 - PR Newswire
CollPlant to Present at the 2025 International Conference on Biofabrication
CollPlant to Present at the 2025 International Conference on Biofabrication PR Newswire
25.08.25 - PR Newswire
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference PR Newswire
20.08.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire
05.08.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS PR Newswire
14.07.25 - PR Newswire
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations PR Newswire
09.06.25 - PR Newswire
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES PR Newswire
04.06.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-​BASED FORMULATIONS USABLE AS SOFT TISSUE ...
30.05.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-​THE-MARKET UNDER NASDAQ RULES PR Newswire
28.05.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE PR Newswire
14.05.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS PR Newswire
15.04.25 - PR Newswire
CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies
CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies PR Newswire
26.03.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE PR Newswire
19.03.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR ...

Newssuche

Videos

newspaper
02.02.26 -29,21%
Technical Trading Silber Crash!
Silber Short Typ: Turbo Open End WKN: VJ4GQU Hebel: 3,77 Laufzeit: OpenEnd Einstieg: Market ... Mehr »